Reply  by Brothers, Thomas E.
LETTERS TO THE EDITOR
Regarding: “Initial experience with eversion carotid
endarterectomy: Absence of a learning curve for the
first 100 patients”
We read with interest Dr Brothers’ article on his initial experience
with eversion carotid endarterectomy (eCEA).1 Comparing his first
100 patients who underwent eCEA with 100 cases of traditional CEA
and patching (tCEA), he found a significantly higher rate of resteno-
ses 50% in the former (38% vs 6%) and no evidence of a learning
curve. Shunting was also needed more often during eCEA (87% vs
59%), and four carotid occlusions occurred 36 months of eCEA
compared with only one occlusion after tCEA. Hence, the author’s
concern about eCEA, and he urges surgeons undertaking eCEA to
monitor their initial results carefully.
In a recently published study on 1150 CEAs performed in
1000 patients, we compared the outcome of 848 eCEAs with 302
tCEAs.2 Unlike Dr Brothers, we found that eCEA reduced peri-
operative (30-day) mortality (0% vs 1.2%) and stroke risk rates
(0.3% vs 0.6%). In6 years of follow-up, only two restenoses (one
50% and 1 70%) and 1 occlusion occurred in the eversion
group.
Because group comparability in terms of external and intrinsic
vascular risk factors is always crucial, a few years ago we conducted
a prospective randomized study comparing clinical outcome and
incidence of restenosis in 86 patients who had tCEA on one side
and eCEA on the other.3 Selective shunting was statistically higher
in the tCEA group (39.5% vs 1.2%), and patched patients had a
slightly higher rate of combined transient ischemic attacks and
strokes (7% vs 1.2%). Most importantly, patched patients had a
significantly higher incidence of restenosis50% (4.7% vs 0%) and
combined occlusions and restenoses (13% vs 1.2%), with a signifi-
cantly worse cumulative patency rate and freedom from restenoses
at 2 and 3 years (P  .001).
Several statistically and clinically significant findings relate to
the better early results with eCEA.3 First, the higher incidence of
residual angulations after patching, compared with the lack of
residual distal elongation with eversion (10.5% vs 0%), indicates
that this defect may be a major determinant of perioperative stroke
secondary to primary thrombosis and a predictor for late occlu-
sions. Second, eCEA takes less time than tCEA (mean carotid
cross-clamping time of 9 minutes vs 21 minutes), significantly
reducing the need for shunting (1.2 % vs 39.5%). Finally, eCEA
preserves the original carotid configuration, offering theoretical
hemodynamic advantages in terms of minimizing turbulence and
the potential for restenosis.3,4 So, in our hands eCEA is a safe,
effective, and durable procedure.
Dr Brothers’ results are plausible, but his study has several
weaknesses: (1) being retrospective, the analysis can have no sig-
nificant clinical implications; (2) the timing of enrollment differs
between the groups, (3) the incidence of important risk factors
such as diabetes and hypertension in each group and (4) the drop
out rate are not known; (5) carotid plaque morphology (low vs
high embolic risk) is never mentioned, and (6) no carotid imaging
was performed on the restenoses.
We agree with Dr Brothers that it is always wise to carefully
monitor initial results after adopting a new technique, bearing in
mind the experience of other colleagues.
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Reply
Dr Baracchini and his colleagues are to be congratulated for
their excellent results with eversion carotid endarterectomy. While
laudable, their findings of reduced perioperative 30-day mortality
and stroke with the eversion technique do not appear to be
statistically significantly lower than their outstanding results with
traditional endarterectomy and patching (my calculation using
Fisher’s exact test). Certainly, their extremely low rate of restenosis
of1% in their retrospective study appears to be far superior of that
of 3.6% documented for eversion endarterectomy in the much
larger prospective, randomized Eversion Endarterectomy versus
Standard Trial (EVEREST) trial.1 Clearly, few vascular surgeons
have been able to achieve the surgical precision of Dr Baracchini
with this technique, and I welcome his comments.
I readily acknowledge that my report suffers from all of the
inherent weakness of a retrospective study, as does his own 2004
study. Although not reported in my article, there were no differ-
ences in the prevalence of diabetes and hypertension between the
groups. The dropout rate is included with the life-table analysis.
Finally, although I do share his intellectual curiosity regarding
the angiographic appearance of the carotids detected to have
50% stenosis by duplex, ethically, I did not feel that I could study
these patients angiographically unless their degree of stenosis was
80%. I am glad that we agree that all surgeons must carefully
monitor their own results.
Thomas E. Brothers, MD
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Regarding “eNOS G894T polymorphism as a mild
predisposing factor for abdominal aortic aneurysm”
Fatini, et al1 recently reported a very interesting study that
evaluated the role of three polymorphisms of the endothelial nitric
oxide synthase (eNOS) gene (T-786C, b/a intron 4, and G894T)
in the predisposition of abdominal aortic aneurysm (AAA). In this
study, the distributions of these polymorphisms were compared
between 250 patients with AAA and 250 healthy subjects with a
negative history of cardiovascular disease. A significant difference in
genotype distribution and allele frequency was observed for the eNOS
G894T polymorphism but not for the others. A possible explanation
for this observation given by the authors is that the eNOS Glu298
and Asp298 variants are differently processed in the cells. It was
suggested that the Asp298 variant might be more susceptible to
inactivation by cleavage by proteases, thus impairing eNOS func-
tion.2
It is important, however, to mention that there is evidence
that the increase in the susceptibility of the eNOS-Asp298 variant
likely results from an artefact of Western blotting preparation.3
This occurs because of acidification during the boiling of the
sample with standard Laemmli buffer. In this manner, the pH of
the sample solution becomes more acid, causing protein degrada-
tion, principally of the Asp-Pro bond, which is particularly suscep-
tible to acid hydrolysis. This finding was demonstrated when
another buffer (lithium dodecyl sulfate) more resistant to pH
changes was used in a sample preparation, and no fragmentation of
Asp variant was observed. Recently, this finding was reproduced.4
That study also demonstrated that there were no significant
differences in intracellular-specific activity and localization in the
plasma membrane and Golgi between eNOS-Glu298 and eNOS-
Asp298. Nevertheless, isolated protein from culture cells was un-
successful in assessing the complex intracellular regulation of
eNOS that is modulated by a number of factors. Thus, it is likely
that any relationship between the genetic variants of eNOS and
cardiovascular disease is due to this being an indirect marker of the
genetic association rather than a direct functional effect, or possibly
an association of Asp variant with an unknown protein expressed
under pathologic conditions.
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Regarding “Midterm outcome of endovascular repair
of ruptured abdominal aortic aneurysms”
I read with great interest the findings of Hechelhammer et al1
on endovascular stenting of ruptured abdominal aortic aneurysms
(rAAAs). Substantial evidence has yet to show a significant im-
provement in outcome with endovascular repair, although it is the
direction that vascular surgery is heading.
When drawing conclusions from this article, it is important to
realize how the authors have classified a rAAA. On computed
tomography (CT) scan, extravasation was detected in only 35.1%
of the patients. The detection of a hematoma on CT scan was
suggestive of rupture, but how long did this occur prior to presen-
tation? It further states that 5 of 37 patients had no identifiable site
of “rupture” on CT. It describes how only hemodynamically stable
patients were included, with no parameters mentioned. Fifteen of
the 37 patients were transferred from referring hospitals.
If we are to successfully compare endovascular repair with
other studies, it is vital that we categorize the patient sample as
accurately at possible. The percentage drop in blood pressure, the
pulse rate, the duration since onset of symptoms, and the blood
hemoglobin, pH, or base excess on admission are all examples of
possible parameters that could be measured to help form a grading
system for severity of rAAA. Almost half (40.5%) of the patients
were transferred, confirming a lack of urgency to intervene. A
grading system of the clinical severity of the rupture with a timing
element representing the need to repair must be introduced to
make accurate comparisons between different endovascular rAAA
series.
Hechelhammer et al make many comparisons with open repair
of rAAAs, yet conclude that the two treatments are not comparable
in this study, which I would agree with. Nevertheless, an overall
comparison between the two techniques needs to be made if it is to
further current clinical practice through evidence-based medicine.
Demographic comparisons between the open and endovascular
repair groups should be made, and the outcome of stable patients
(demonstrated by suitable parameters) compared, either by ran-
domizing their treatment or by comparing results with a similar
center or with results from open repair at the same center from the
years preceding the study.
It would be interesting to note the share of the repair between
surgeon and radiologist. Common complications seen in open
repair such as myocardial infarction and pneumonia are not dis-
cussed, nor are stent infections. Clarification of their absence
would help in future comparisons. Thoughts for the future include
the incidence of radiation-induced tumors from repeated CT
scanning required for follow up and the impact on the radiology
suite encountered when radiologists are required at short notice to
perform these lengthy procedures.
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